Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease-Reference-Cited by-同舟云学术

Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease

Published:2017-03-20 Issue:5 Volume:470 Page:575-582
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

Pileri Alessandro^ORCID,Agostinelli Claudio,Sessa Maurizio,Quaglino Pietro,Santucci Marco,Tomasini Carlo,Grandi Vieri,Fava Paolo,Astrua Chiara,Righi Simona,Patrizi Annalisa,Pileri Stefano A.,Pimpinelli Nicola

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00428-017-2107-1.pdf

Reference51 articles.

1. Pileri A Jr, Patrizi A, Agostinelli C et al (2011) Primary cutaneous lymphomas: a reprisal. Semin Diagn Pathol 28:214–233

2. Quaglino P, Pimpinelli N, Berti E et al (2012) Mycosis fungoides: disease evolution of the “lion queen” revisited. G Ital Dermatol Venereol 147:523–531

3. Scarisbrick JJ, Prince HM, Vermeer MH et al (2015) Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: effect of specific prognostic markers on survival and development of a prognostic model. J Clin Oncol 33:3766–3773

4. Pimpinelli N, Olsen EA, Santucci M et al (2005) Defining early mycosis fungoides. J Am Acad Dermatol 53:1053–1063

5. Cerroni L (2006) Lymphoproliferative lesions of the skin. J Clin Pathol 59:813–826

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines;Frontiers in Cardiovascular Medicine;2023-11-24

2. PD-1 and PD-L1 expression in mycosis fungoides and Sézary Syndrome;Italian Journal of Dermatology and Venereology;2022-08

3. TOX Expression in Mycosis Fungoides and Sezary Syndrome;Diagnostics;2022-06-29

4. The Microenvironment’s Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic Implications;Cells;2021-10-17

5. CD303 (BDCA-2) – a potential novel target for therapy in hematologic malignancies;Leukemia & Lymphoma;2021-09-06